68th Annual Scientific Meeting of the Cardiac Society of Australia and New Zealand Dec 11, 2020 20201211 Nov 13, 2020 Virtual The Cardiac Society of Australia and New Zealand is the professional body for cardiologists and those working in the area of cardiology including researchers, scientists, cardiovascular nurses, allied health professionals and other healthcare workers. The Society is the chief advocacy group for the profession and aims to facilitate training, professional development and improve medical practice to enhance the quality of care for patients with cardiovascular disease. The 68th Annual Scientific Meeting of the Cardiac Society of Australia and New Zealand will be virtual and will provide an invaluable educational experience from lecturers, both International and Australasian speakers, and the opportunity to review hundreds of scientific abstracts highlighting updates on the most critical topics in cardiology. /content/dam/pmiscience/default-fallback-thumbnails/conference/pmi-science-conference.png

      68th Annual Scientific Meeting of the Cardiac Society of Australia and New Zealand

      Date
      Dec 11, 2020 - Nov 13, 2020
      Location
      Virtual
      The Cardiac Society of Australia and New Zealand is the professional body for cardiologists and those working in the area of cardiology including researchers, scientists, cardiovascular nurses, allied health professionals and other healthcare workers. The Society is the chief advocacy group for the profession and aims to facilitate training, professional development and improve medical practice to enhance the quality of care for patients with cardiovascular disease. The 68th Annual Scientific Meeting of the Cardiac Society of Australia and New Zealand will be virtual and will provide an invaluable educational experience from lecturers, both International and Australasian speakers, and the opportunity to review hundreds of scientific abstracts highlighting updates on the most critical topics in cardiology.

      PMIScience.com is operated by Philip Morris International for the purpose of publishing and disseminating scientific information about Philip Morris International’s efforts to develop and assess products that have the potential to reduce individual risk and population harm associated with tobacco use. This site is for use by scientists, the public health and regulatory communities, and other stakeholders with an interest in tobacco policy. The purpose of this site is not for advertising or marketing. It is not intended for use by consumers.

      Reduced Risk Products ("RRPs”) is the term we use to refer to products that present, are likely to present, or have the potential to present less risk of harm to smokers who switch to these products versus continuing smoking. PMI has a range of RRPs in various stages of development, scientific assessment and commercialization. Our RRPs are smoke-free products that produce an aerosol that contains far lower quantities of harmful and potentially harmful constituents than found in cigarette smoke.